Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Saccharomyces cerevisiae

ABSTRACT: Transcription profile analysis of S. cerevisiae ZTW1 wild-type and mutant strains

PROVIDER: PRJNA175825 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR570199.fastq.gz	Fastqsanger.gz
	SRR570200.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Saccharomyces cerevisiae

Project description:Transcription profile analysis of S. cerevisiae strains

| PRJNA145581 | ENA

Transcriptional Profiling of a high glucose tolerance Saccharomyces cerevisiae stain by RNA-Seq

Project description:Using RNA-Seq, the transcriptomes of saccharomyces cerevisiae wild-type MF02 and UV mutant strain UV02_HG were compared under high sugar conditions. Based on this analysis, we found that different expressions between two strains mainly focus on the transport and modification of proteins and metabolism of carbon

2019-09-06 | GSE86448 | GEO

Expression analysis of fast-fermenting high-gravity maltose Saccharomyces cerevisiae Y55 mutants

Project description:Investigation of whole genome gene expression level changes in three S. cerevisiae Y55 mutants, compared to the wild-type strain. The UV-induced mutations enable the mutant strains to ferment high-gravity maltose faster than the WT. The mutants analyzed in this study are further described in Baerends, R.J.S., J.L. Qiu, L. Gautier, and A. Brandt. A high-throughput system for screening of fast-fermenting Saccharomyces cerevisiae strains. Manuscript in preparation.

2013-10-25 | GSE25015 | GEO

Saccharomyces cerevisiae

Project description:Transcript and Proteomic Analyses of Wild-Type and GPA2 Mutant Saccharomyces cerevisiae Strains

| PRJNA100051 | ENA

Expression data of antibody fragments from Saccharomyces cerevisiae

Project description:Saccharomyces cerevisiae has been used as a secretion host for production of various products, including pharmaceuticals. However, few antibody molecules have been functionally expressed in S. cerevisiae due to the incompatible surface glycosylation. Our laboratory previously isolated a group of yeast mutant strains with different α-amylase secretory capacities, and these evolved strains have showed advantages for production of some heterologous proteins. However, it is not known whether these secretory strains are generally suitable for pharmaceutical protein production. Here, three non-glycosylated antibody fragments with different configurations (Ran-Fab fragment Ranibizumab, Pex-the scFv peptide Pexelizumab, and Nan-a single V-type domain) were successfully expressed and secreted in three background strains with different secretory capacities, including HA (wild type), MA (evolved strain), and LA (evolved strain). However, the secretion of Ran and Nan were positively correlated with the strains’ secretory capacity, while Pex was most efficiently secreted in the parental strain. Therefore, transcriptional analysis was performed to explore the fundamental changes triggered by the expression of the different pharmaceutical proteins in these selected yeast strains.

2021-07-06 | GSE179391 | GEO

Saccharomyces cerevisiae

Project description:Yeast FAIRE_testing wild-type and mutant strains

| PRJNA104547 | ENA

Saccharomyces cerevisiae

Project description:Expression data for UV time course in Saccharomyces cerevisiae wild-type and mutant strains

| PRJNA117509 | ENA

Saccharomyces cerevisiae

Project description:RNA-Seq data of in the wild-type and agp2Δ mutant strains of Saccharomyces cerevisiae.

| PRJNA1064289 | ENA

Saccharomyces cerevisiae

Project description:S. cerevisiae RNA-seq in wild-type and sir2Δhst1Δ strains